Arcadia Biosciences, Inc. — Director's Dealing 2018

Mar 22, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2018-03-19

Reporting Person: Reiter Sarah (Chief Commercial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-03-19	Stock Option (right to buy)	$45.69	A	10000	Acquired	2028-03-19	Common Stock (10000)	Direct

Footnotes

F1: The option vests with respect to 25% of the total securities subject to the option on the first anniversary of the date of award, or March 19, 2019, with the remaining 75% vesting in 36 equal installments beginning March 31, 2019 and ending February 28, 2022, subject to the Participant's continued service.